Mirati Therapeutics reported $71.79M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Alnylam Pharmaceuticals ALNY:US $ 187.63M 32.92M
Amgen AMGN:US $ 6706M 180M
Astellas Pharma 4503:JP Y 325523M 620M
AstraZeneca AZN:LN 9866M 1646M
Bayer BAYN:GR € 9781M 1073M
Biocryst Pharmaceuticals BCRX:US $ 40.99M 8.96M
Bluebird Bio BLUE:US $ 22.68M 15.2M
Bristol Myers Squibb BMY:US $ 11624M 79M
Eisai 4523:JP Y 163458M 35436M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Exelixis EXEL:US $ 328.42M 56.75M
Gilead Sciences GILD:US $ 7421M 1204M
GlaxoSmithKline GSK:LN 9077M 985M
IONIS PHARMACEUT IONS:US $ 133M 7.25M
Johnson & Johnson JNJ:US $ 23338M 26M
Merk MRK:US $ 13154M 1752M
Moderna Inc MRNA:US 4.97B 615M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Novartis NOVN:VX SF 13367M 73M
Pfizer PFE:US $ 24094M 5117M
Puma Biotechnology PBYI:US $ 46.24M 7.14M
Sarepta Therapeutics SRPT:US $ 189.41M 25.32M
Seattle Genetics SGEN:US $ 424.06M 35.58M
Takeda 4502:JP Y 844820M 104783M
Ultragenyx Pharmaceutical RARE:US $ 81.65M 5.33M
YTE INCY:US $ 812.99M 107.28M